449
Views
25
CrossRef citations to date
0
Altmetric
Original Article

The relationship between Toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: a new approach

ORCID Icon, ORCID Icon & ORCID Icon
Pages 57-62 | Received 27 Mar 2017, Accepted 25 Sep 2017, Published online: 09 Oct 2017

References

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-V). 5th ed. Washington (DC): American Psychiatric Association; 2013.
  • Kendall PC, Pimentel SS. On the physiological symptom constellation in youth with generalized anxiety disorder (GAD). J Anxiety Disord. 2003;17:211–221.
  • Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication – Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49:980–989.
  • Mackintosh MA, Gatz M, Wetherell JL, et al. A twin study of lifetime generalized anxiety disorder (GAD) in older adults: genetic and environmental influences shared by neuroticism and GAD. Twin Res Hum Genet. 2006;9:30–37.
  • LeDoux J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry. 1998;44:1229–1238.
  • Abelson JL, Glitz D, Cameron OG, et al. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry. 1991;48:157–162.
  • Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry. 1995;56:38–48.
  • Pezze MA, Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol. 2004;74:301–320.
  • Flament MF, Whitaker A, Rapoport JL, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988;27:764–771.
  • Heyman I, Fombonne E, Simmons H, et al. Prevalence of obsessive – compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry. 2001;179:324–329.
  • Westenberg H, Fineberg N, Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr. 2007;12:14–27.
  • Swedo SE, Leonard H, Garvey M. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–271.
  • Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873–880.
  • Coughlin SS. Anxiety and depression: linkages with viral diseases. Public Health Rev. 2012;34:1–17.
  • Phillips AC, Carroll D, Khan N, et al. Cytomegalovirus is associated with depression and anxiety in older adults. Brain Behav Immun. 2008;22:52–55.
  • Witthauer C, Gloster AT, Meyer AH, et al. Comorbidity of infectious diseases and anxiety disorders in adults and its association with quality of life: a community study. Front Public Health. 2014;2:80.
  • Adam Y, Meinlschmidt G, Lieb R. Associations between mental disorders and the common cold in adults: a population-based cross-sectional study. J Psychosom Res. 2013;74:69–73.
  • Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, et al. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull. 2007;33:741–744.
  • Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006;32:200–202.
  • Flegr J. Effects of toxoplasma on human behavior. Schizophr Bull. 2007;33:757–760.
  • Levinson W, Jawetz E. Medical microbiology and immunology: examination and board review. 4th ed. Stamford (CT): Appleton and Lange Ltd.; 1996. p. 276–77.
  • Garcia L. Diagnostic medical parasitology. 4th ed. California: ASM Press; 2001.
  • Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders-overview of evidence and mechanisms. Folia Parasitol (Praha). 2010;57:105–113.
  • Havlicek J, Gasova ZG, Smith AP, et al. Decrease of psychomotor performance in subjects with latent ‘asymptomatic’ toxoplasmosis. Parasitology. 2001;122:515–520.
  • Flegr J, Havlicek J, Kodym P, et al. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis. 2002;2:11.
  • Yereli K, Balcioğlu IC, Ozbilgin A. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci Int. 2006;163:34–37.
  • Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980–988.
  • Gökler B, Ünal F, Pehlivantürk B, et al. Reliability and validity of Kiddie schedule for affective disorders and schizophrenia for school-age children, present and lifetime (K-SADS-PL). Çocuk Ve Gençlik Ruh Sağlığı Dergisi. 2004;11:109–116.
  • Spielberger CD. Manual for the state-trait anxiety inventory for children. Palo Alto (CA): Consulting Psychologists Press; 1973.
  • Özusta HŞ. Turkish standardization, reliability and validity of state trait anxiety inventory for children. Türk Psikoloji Dergisi. 1995;10:32–44.
  • Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children’s Yale-Brown obsessive-compulsive scales: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844–852.
  • Yücelen EG, Arman RA, Topçuoğlu V, et al. Çocuklar için Yale-Brown Obsesif Kompulsif Ölçeği Geçerlilik Güvenilirlik Çalışması. 12th. Istanbul: Turkish Child and Adolescent Psychiatry Congress, Poster Presentation; 2002.
  • Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science. 1948;108:660–663.
  • Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976.
  • Prandovszky E, Gaskell EA, Martin H, et al. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 2011;6:e23866.
  • Kar N, Misra B. Toxoplasma seropositivity and depression: a case report. BMC Psychiatry. 2004;4:1.
  • Yagmur F, Yazar S, Temel HO, et al. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int. 2010;199:15–17.
  • Torrey EF, Bartko JJ, Lun ZR, et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2007;33:729–736.
  • Henriquez SA, Brett R, Alexander J, et al. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation. 2009;16:122–133.
  • Oei TP, King MG. Catecholamines and aversive learning: a review. Neurosci Biobehav Rev. 1980;4:161–173.
  • Millan MJ. The neurobiology and control of anxious states. Prog Neurobiol. 2003;70:83–244.
  • Thiel CM, Schwarting RK. Dopaminergic lateralisation in the forebrain: relations to behavioural asymmetries and anxiety in male Wistar rats. Neuropsychobiology. 2001;43:192–199.
  • Stein DJ, Westenberg HG, Liebowitz MR. Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry. 2002;63:12–19.
  • Etkin A, Prater KE, Schatzberg AF, et al. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 2009;66;1361–1372.
  • Koenen KC, Amstadter AB, Ruggiero K, et al. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety. 2009;26:309–315.
  • Markovitz AA, Simanek AM, Yolken RH, et al. Toxoplasma gondii and anxiety disorders in a community-based sample. Brain Behavior Immunity. 2015;43:192–197.
  • Renynghe de Voxrie GV. Anafranil in obsessive neurosis. Arch Neurol Belg. 1968;68:787–792.
  • Capstick N. Chlorimipramine in obsessional states. A pilot study. Psychosomatics. 1971;12:332–335.
  • Snider LA, Swedo SE. Nature and treatment of obsessive compulsive disorder. In: Panksepp J, editor. Textbook of biological psychiatry, Hoboken (NJ): Wiley-Liss, Inc.; 2004. p. 367–393.
  • Carruthers VB, Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr Bull. 2007;33:745–751.
  • Brynska A, Tomaszewicz-Libudzic E, Wolanczyk T. Obsessive-compulsive disorder and acquired toxoplasmosis in two children. Eur Child Adolesc Psychiatry. 2001;10:200–204.
  • Miman O, Mutlu EA, Ozcan O, et al. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res. 2010;177:263–265.
  • Flegr J, Horáček J. Toxoplasma-infected subjects report an obsessive-compulsive disorder diagnosis more often and score higher in obsessive-compulsive inventory. Eur Psychiatry. 2017;40:82–87.
  • Shugart MA. Child psychiatry consultations to pediatric inpatients: a literature review. Gen Hosp Psychiatry. 1991;13:325–336.
  • Denys D, Fluitman S, Kavelaars A, et al. Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology. 2004;29:945–952.
  • Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun. 2002;16:1–16.
  • Zorrilla EP, Luborsky L, McKay JR, et al. The relationship of depression and stressors to immunological assays: a metaanalytic review. Brain Behav Immun. 2001;15:199–226.
  • Miller GE, Cohen S, Herbert TB. Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med. 1999;61:850–860.
  • Glaser R, Rice J, Speicher CE, et al. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behav Neurosci. 1986;100:675–678.
  • Kiecolt-Glaser JK, Garner W, Speicher C, et al. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med. 1984;46:7–14.
  • Sadock BJ, Sadock VA. Kaplan and Sadock’s concise textbook of clinical psychiatry. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.